Onchocerciasis-associated epilepsy: Charting a path forward

•Onchocerciasis-associated epilepsy (OAE) is a preventable and treatable condition.•OAE is an important public health problem in areas of high O. volvulus transmission.•A morbidity management and disability prevention programs is needed for OAE.•More access to anti-seizure medication is needed in on...

Full description

Saved in:
Bibliographic Details
Published in:Seizure (London, England) England), 2024-04
Main Authors: Van Cutsem, G, Siewe Fodjo, JN, Hadermann, A, Amaral, L-J, Trevisan, C, Pion, S, Colebunders, R
Format: Article
Language:English
Subjects:
Epilepsy
Ivermectin
Nodding syndrome
Onchocerciasis
Prevention
Treatment
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Onchocerciasis-associated epilepsy (OAE) is a preventable and treatable condition.•OAE is an important public health problem in areas of high O. volvulus transmission.•A morbidity management and disability prevention programs is needed for OAE.•More access to anti-seizure medication is needed in onchocerciasis endemic areas.•Research to identify the pathogenesis of OAE needs to be intensified. This narrative review intends to inform neurologists and public health professionals about Onchocerciasis-Associated Epilepsy (OAE), a neglected public health problem in many remote onchocerciasis-endemic areas. For epidemiological purposes, we define OAE as sudden-onset of convulsive and non-convulsive seizure types, including head nodding seizures (nodding syndrome) in a previously healthy child aged 3 to 18 years in the absence of any other obvious cause for epilepsy, all happening within an area with high ongoing Onchocerca volvulus transmission. Several OAE pathophysiological mechanisms have been proposed, but none has been proven yet. Recent population-based studies showed that strengthening onchocerciasis elimination programs was followed by a significant reduction in the incidence of OAE and nodding syndrome. Treating epilepsy in onchocerciasis-endemic regions is challenging. More advocacy is needed to provide uninterrupted, free access to anti-seizure medication to persons with epilepsy in these remote, impoverished areas. It is crucial todevelop policies and increase funding for the prevention and treatment of OAE to reduce the associated burden of disease, notably via the establishment of morbidity management and disability prevention programs (MMDP). Moreover, effective collaboration between onchocerciasis elimination and mental health programs is imperative to alleviate the burden of OAE. This synergy promises reciprocal advantages and underscores the need for a comprehensive approach to address this multifaceted challenge.
ISSN:1059-1311
1532-2688
DOI:10.1016/j.seizure.2024.04.018